Suchergebnisse - "Kim, Yoon Jun"

PubPharm (24)

1

Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Fung, S. | Pan, C. | Wong, G. | +17

2

Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model : A Multinational Study

enthalten in: The American journal of gastroenterology | 2023

von Hur, M. | Park, M. | Yip, T. | +28

3

Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients : A Multicenter, Randomized Study

enthalten in: Journal of Korean medical science | 2023

von Jang, H. | Yu, S. | Lee, H. | +6

4

An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B

enthalten in: Journal of hepatology | 2022

von Kim, H. | Lampertico, P. | Nam, J. | +33

5

Tenofovir Alafenamide for Drug-Resistant Hepatitis B : A Randomized Trial for Switching From Tenofovir Disoproxil Fumarate

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Byun, K. | Choi, J. | Kim, J. | +7

6

Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients

enthalten in: Hepatology international | 2021

von Chon, H. | Ahn, S. | Kim, Y. | +4

7

Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response

enthalten in: Journal of viral hepatitis | 2021

von Na, J. | Sinn, D. | Lee, J. | +12

8

Discovery of Novel Pyrimidine-Based Capsid Assembly Modulators as Potent Anti-HBV Agents

enthalten in: Journal of medicinal chemistry | 2021

von Kim, W. | Kang, J. | Park, M. | +5

9

Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B : Results of 192-week phase 3 trial

enthalten in: Clinical and molecular hepatology | 2021

von Song, D. | Kim, W. | Ahn, S. | +23

CommentIn: Clin Mol Hepatol. 2021 Apr;27(2):281-282. - PMID 33687857

10

Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance : a nationwide multicentre study

enthalten in: Gut | 2020

von Kim, M. | Kim, S. | Sinn, D. | +28